chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received both vaccines in separate arms on Weds, 9/26. She reports feeling alright on Thursday with mild arm soreness, but waking up on Friday 9/28 with significant arm soreness (we told her it was possible), but more so concerning is that she reported significant disorientation, dizziness, and confusion that she is attributing to the vaccines. Spoke with the patient for the first time on 10/1 and she reports that she is forgetting dates and is still experiencing confusion and changes in vision. I suggested she call her physician to report her symptoms, and that they may do further testing to rule out other causes and that they may not be attributable to vaccine but that the doctor should be contacted regardless. She is concerned that the combination of the two vaccines has resulted in these symptoms.
Left deltoid area is swollen and red about 5 cm in diameter.  No discharge full range of motion dx: cellulitis referred to ER for further eval. F/u 2-3 days.
The patient had already received his 2nd dose of a 2 dose series and was given a 3rd. The patient needed the 2nd dose of Men B which we do not have in this clinic.  There was not a reaction to the 3rd dose given.
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Oct2021 at 16:00 as dose 3 (booster), single (Lot number: FF2588) at the age of 45 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Peanuts" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (08Aug2022) Positive, notes: Tested positive again after 3 days of finishing Paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: Patient did not take any other medication in 2 weeks. No follow-up attempts are possible. No further information is expected.
felt cold; fever; nausea; arm sore and shooting to neck and elbow; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (felt cold), PAIN IN EXTREMITY (arm sore and shooting to neck and elbow), PYREXIA (fever) and NAUSEA (nausea) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm sore and shooting to neck and elbow). On 27-Feb-2021, the patient experienced NASOPHARYNGITIS (felt cold), PYREXIA (fever) and NAUSEA (nausea). On 02-Mar-2021, NASOPHARYNGITIS (felt cold), PAIN IN EXTREMITY (arm sore and shooting to neck and elbow) and PYREXIA (fever) had resolved. On 04-Mar-2021, NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided   This case was linked to MOD-2021-114223 (Patient Link).
Pt vaccinated /w MMR developed fever but not verified, 3 days /p vx onset of parotitis, primarily on lt side. lasted seven days. Seen in PM on 8May90 @ Urgent care cntr & 9MAY90 @ PMDs office.
I became light headed and dizzy this happened with every Covid vaccination. But for the Booster I felt a metallic taste in my mouth at the same time I got light headed, about 5-10 minutes after the injection. By the next day my arm was sore and a red welt formed at the injection site. The welt got bigger about 2-3 inches, warm, hurting and itchy. It remained that way for 2 weeks as did the metallic taste. I contracted Covid 2 weeks after the Booster and the injection site became very itchy and my skin became very dry. The itching subsided 3 weeks later but the dryness has remained.
Pt found unresponsive in hospital room with large amount of vomit.  Patient pronounced dead shortly after with cause of death noted to be aspiration pneumonia with hypoxemia leading to cardiac arrest.  Pt received vaccine 1 month prior so I wanted to report this.
ACUTE RESPIRATORY FAILURE 5/24/2022 ACUTE RESPIRATORY FAILURE  RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/8/2022 ACUTE RESPIRATORY FAILURE
.5 mL was given intradermally instead of subcutaneously. PT reported minor itching and no other symptoms.
Starting in October 2021 I noticed hair loss in my hair line in front and back of head.  In late October of 2021 I visited the  dermatologist for review and started to receive monthly cortisone treatments and prescription of clobetasol ,05%.  By March, I had lost 80 percent of my hair and I was diagnosed by biopsy with alopecia areata.  Then dermatologist stopped treatment and suggested contacting a doctor conducting clinical trials.  At this point I ceased all medical treatments and bought a wig.  By the end of April, I had lost all of my body hair  including eyelashes and eyebrows.  All of the hair in other places on my body has disappeared as well.  I have Alopecia totalis.  There is not any history of this in my family nor did I have issues prior to contracting this immune deficiancy.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 68-year-old female patient who received SHINGRIX for prophylaxis. In June 2018, the patient received SHINGRIX. In June 2018, less than a month after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were reported as follows: The reporter was the patient's brother. The patient received SHINGRIX sometime in June 2018 and had arm pain and soreness. The event was resolved after a few days. This case was linked with case US2018177084, reported by the same reporter.
pain in the shoulder. pain when left up the arm, get dressed, take a shower, anytime raising the arm.
Per patient's mother, patient experienced some fatigue and fevers the day after the immunization. Patient started to show large welts on the upper side of his right body 2 days post vaccination (shot was administered in the left). Referred the patient's mother to call the pediatrician's office to follow up regarding the adverse effect of the shot.
Purple Toes and extreme foot pain particularly standing. Feet feel very cold, like your toes might break off.
I have not a menstrual cycle since receiving my 2nd shot.  It's now been 2 months since my last cycle.  Yet I am symptomatic of a cycle (cramping, bloating) but the menses do not come.  While I am 48, I have been regular and consistent with my periods up until the 2nd shot and have never been this late (not pregnant, did an OTC test to be extra sure).  A similar case is being reported by colleague of mine.  Same age, same shot, same week and yet no cycle has come yet for her since the 2nd shot.  Given that it's both of us in the same boat, it's more than coincidence and more than "perimenopause" - what is the likely hood we both went into a weird peri-cycle the month we received the shot?
She got tired the day before and on the 16th of May 2021 she suddenly collapsed and died immediately. She did not complain of chest pain her heart just stopped.
Patient reported substantial swelling and heat and the site of injection. Swelling occurred approximately 24 hours after the injection. It was accompanied by fatigue and flu-like symptoms. Reaction remitted after one day.
Mild rash, on my neck and my upper chest not raised; Somewhat itchy; Light red; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Mar2021 (Lot number and expiration date was not reported) as dose 1, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medication(s) included levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported. On 15Mar2021, the patient developed a rash on her chin/neck and spread to her upper chest. It was a light red rash somewhat itchy, it was not raised. It was not hives. The patient was concerned and called her physician, and after she took diphenhydramine (BENADRYL) 25 mg tablet, 2DF (each one with 6 hours apart) on 18Mar2021 and rash was not resolved and discontinued BENADRYL.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
SEVERE BACK PAIN; This spontaneous report received from a consumer concerned a 26 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 29-APR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 2021, the subject experienced severe back pain. The action taken with covid-19 vaccine was not applicable. The outcome of severe back pain was not reported. This report was non-serious.
22OCT97 evening itching;23OCT97 AM itching & redness;23OCT97 afternoon huge hives saw MD began DPH q 4hr;
Patient developed rash at the injection site 7 days after injection. Patient has no symptoms just the late onset rash
very tired; mild Fever; flu like symptoms; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st February 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 5 months after receiving Shingrix, the patient experienced tiredness, fever and influenza-like symptoms. On an unknown date, the outcome of the tiredness, fever and influenza-like symptoms were unknown.   It was unknown if the reporter considered the tiredness, fever and influenza-like symptoms to be related to Shingrix.  Additional information was provided as follows: The patient experienced mild fever, tiredness and flu like symptoms after receiving 1st dose of Shingrix. The reporter consented to follow up. For the tolerance of 2nd dose, refer case- US2020AMR190335.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR190335:Same patient- 2nd dose
9-20-10 Received TDAP (Employee). 9-24-10 Called employee health c/o temp = 99.8. 9-24-10 Went to ED, temp = 102.4. F/U with Employee clinic.
"Covid Arm" one and a half inch raised red area with a hard slightly lighter and raised center.
Side effects:  fever, muscle aches, headache, mild nausea, continued for 7 days.
documentation of s/s starting on 12/18 of writhing movement in her chair, change in mental status, periods of expressive aphasia, involuntary movements of legs and arms, moaning and whining,.
Developed fever, step parent noticed abnormal breathing and shaking all over, lasted 30 seconds. Went to ER, diagnosed with simple febrile seizure.
Have songs playing in my head; Unwanted thoughts; Sleeplessness; Swollen glands; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 31Mar2021 at 22:30 (at the age of 40-year-old ) as a single dose for COVID-19 immunisation. Medical history included epilepsy. Concomitant medication included lamotrigine (LAMICTAL) taken from an unknown date for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on 10Mar2021 at 23:45 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 22:45, the patient experienced sleeplessness, unwanted thoughts, swollen glands and had songs playing in his head (thinking abnormal). The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event sleeplessness, unwanted thoughts, swollen glands and thinking abnormal were not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a physician concerning a 24 year old female who in  2007 was vaccinated with the first dose of 0.5 ml Gardasil intramuscularly. There were no adverse events. The second Gardasil 0.5 ml dose was given intramuscularly on 29-MAY-2007. On 30-MAY-2007 the patient experienced significant rash and hives. The patient's significant rash and hives persisted. No lab testing was performed. Additional information has been requested. 10/08/07 This is in follow-up to report(s) previously submitted on 6/14/2007. Initial and follow-up information has been received from a physician and a health care professional concerning a 23 year old female who in 2007 was vaccinated intramuscularly with the first 0.5 ml dose of the GARDASIL. There were no adverse events. The second GARDASIL (Lot # 657622/0388U) 0.5 ml dose was given intramuscularly on 29-MAY-2007. On 29-MAY-2007, the patient experienced injection site warmth, redness, and hives around the site. The outcome of the patient's injection site redness, warmth and hives was unknown. Additional information is not expected.
On 05/07/2021, one month after the second dose of Pfizer COVID-19 vaccine, the patient had extreme vertigo.  She was taken to the ER where she received IV medications.  She is unsure what she was given in the ER but  she was sent home with a prescription for diazepam and meclizine.  One 06/01/2021, the patient experienced another vertigo episode.  She took the prescription diazepam and meclizine.  The medications relieved the symptoms after about three days of taking the medication.  On 06/21/2021, that patient woke up with vertigo again.  She has taken the first dose of her prescription diazepam and meclizine.   The vertigo has improved but not resolved at the time of this interview.  The patient has never had vertigo and believes it is a side effect of the COVID-19 vaccine.  The patient states her doctor believed the first episode was caused by a virus and the subsequent episodes were caused by fluid in the ear.
4PM began coughing-refused to eat-did not take bottle; felt warm-no temp taken; 10Pm coughing inc to Er t101; rx breathing treatments & decongestant given; still coughing & wheezing to PMD given ATB; Wednesday still pale;
pt recvd vax & the next day devel swelling & pain @ inject site; also had soreness of the neck & back; pt took DPH & stayed in bed several hrs;
Slight shortness of breath and rapid heartbeat, 3am for 30 sec and  2nd episode at 6:45 am for 1 minute
When my duaghter was born, she had an apgar score of 9, and was deemed healthy. Within 24 hours of the shot she began to not want to feed, before becoming inconsolable. This progressed to serious periods of apnea to the point that she would turn blue. These episodes continued for approximately a week. We spent approximately 12 days in the hospital before being relased on Febraury 15th. Ten of those days were spent at hospital. All additional tests performed by the hospital came back with normal results, but the doctors never discussed the possiblity of a reaction with me, despite the fact that apnea has been previously observed in premature newborns following this shot.
The patient received a MENVEO vaccination and convulsed for 20-30 seconds.
severe diarrhea; terrible headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 80-year-old female patient received BNT162b2 (BNT162B2), on 24Aug2020 as dose 1, single (Batch/Lot number: unknown) at the age of 77 years for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "severe diarrhea"; HEADACHE (non-serious), outcome "unknown", described as "terrible headache".  Additional information: She had a very bad reaction to the first dose severe diarrhea and terrible headache. A lot of people had side effects but they went away. Her husband did not have any side effects, maybe he got a placebo.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300190182 Same reporter/patient, same drug/different dose, different AEs.;
Admitted on 11/15 for weakness. Tested positive for COVID 19. Symptoms started 11/12/22- cough, chills, and lightheadedness.
Pt developed subcutaneous nodules of thighs after receiving his vaccine - nodule was aspirated by surgeon and found to be sterile after pt TX with Septra x 10 days.
Pt experienced sore leg w/no fever then 3 days later had sz; Taken to ER & hospitalized;
Sore arm started in the middle of the night--still sore two days later.  General achiness all over.  General tiredness.
Within a minute of the injection, I began to feel a cold sensation that traveled across my shoulder blades beginning at my left shoulder blade.  The healthcare worker came back with my vaccination card within a couple minutes.  I left her know about it.  I had began to feel, but the sensation then spread to the back of my head and down to my lower back.  I felt a little uneasy and had the thought that I probably couldn't drive.  Before the 15 minute observation period was over, I felt better but still had the cool sensation in the back of my head.
This case was reported by a physician via a representative and described the occurrence of erythema in a child subject of unspecified gender who was vaccinated with INFANRIX (GlaxoSmithKline). On an unspecified date the subject received 5th or 4th dose of INFANRIX. At an unspecified time after vaccination with INFANRIX, the subject experienced erythema and swelling. At the time of reporting the outcome of the events was unspecified. It was reported that "the practice" has seen an increase in redness and swelling with the use of INFANRIX used for the 4th and 5th doses. The reporter stated that is more redness and swelling with the INFANRIX pre-filled syringe than compared to using the "Sanofi DTaP vaccine in a vial. The reporter speculated that he increase in redness and swelling with INFANRIX may by due to the air bubble in the INFANRIX pre-filled syringe. The extent of the redness and swelling was not reported, therefore, it is unknown if the redness and swelling is at the injection site location or is more systemic in nature. The number of subjects involved was not known.
Information has been received from a physician concerning a male patient who on an unspecified date was vaccinated with a dose of Zostavax. Three weeks after vaccination, the patient was diagnosed with shingle. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Vaccine was expired on 07-Apr-2022 and administered on 12-Apr-2022 / expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 07-Apr-2022 and administered on 12-Apr-2022 / expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration) in a 90-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 07-Apr-2022 and administered on 12-Apr-2022 / expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 07-Apr-2022 and administered on 12-Apr-2022 / expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 173 doses.   The vial did not undergo any temperature excursions.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up received contains non significant information.
This legal report (initial receipt 02-May-2013) concerns a patient, gender and age not specified. On an unspecified date the patient received a flu shot (manufacturer not specified) and PNEUMOVAX. The batch number 1947AA was provided however it was unclear if this was associated with the flu shot or PNEUMOVAX. A few days after the vaccinations the patient went into a coma. No further details were provided about the event. Reporter's comment: The reporter stated that it was not determined which vaccine (flu shot or PNEUMOVAX) was responsible for the event.
inc temp 102-104-Ibuprofen;deep muscle pain to thighs, arms-Ibuprofen;feeling faint-?LOC x 1 (for a few min per pt);no tx disoriented-acting out of it per mom-no tx;
Autism. A mother reported that her 19-month-old son received an injection of Acel-Imune. At 2 years of age he began to 'regress' in the way he walked; 'walking with legs wide open as if he was just starting to walk.' The mother also stated that the child began to 'lose focus,' slept poorly, was very 'hyper,' and talked  'nonsense.' At 3 years of age, a diagnosis of autism was made. The mother attributed these events to the vaxs he received since 2 months of age. The mother reported that her son was found to have an unspecified immune deficiency shortly after birth. He was 'very sickly' when he was immunized during 1992 and 1993. A copy of this report has been forwarded to Merck, manufacturer of MMR vax.
Strong headache, fever, muscular pain, especially in lower back portion of the body, muscle cramp
Rash x 6 hrs. SP vaccine 1 wk ago. Rash all over body. Rec'd IV Benadryl 50mg. Admitted for 23 hours OBS. Diagnosed as an allergic reaction.